As of 2025-03-17, the Relative Valuation of Precigen Inc (PGEN) is (11.77) USD. This relative valuation is based on P/E multiples. With the latest stock price at 1.80 USD, the upside of Precigen Inc based on Relative Valuation is -753.9%.
The range of the Relative Valuation is (9.96) - (14.04) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 20.9x - 35.7x | 27.5x |
| Forward P/E multiples | 18.0x - 29.5x | 21.9x |
| Fair Price | (9.96) - (14.04) | (11.77) |
| Upside | -653.3% - -879.9% | -753.9% |
| Date | P/E |
| 2025-03-06 | -3.92 |
| 2025-03-05 | -4.05 |
| 2025-03-04 | -3.74 |
| 2025-03-03 | -3.50 |
| 2025-02-28 | -3.63 |
| 2025-02-27 | -3.67 |
| 2025-02-26 | -3.80 |
| 2025-02-25 | -3.63 |
| 2025-02-24 | -3.67 |
| 2025-02-21 | -4.01 |
| 2025-02-20 | -4.13 |
| 2025-02-19 | -4.26 |
| 2025-02-18 | -4.24 |
| 2025-02-14 | -4.11 |
| 2025-02-13 | -4.15 |
| 2025-02-12 | -4.01 |
| 2025-02-11 | -3.57 |
| 2025-02-10 | -3.74 |
| 2025-02-07 | -3.57 |
| 2025-02-06 | -3.36 |
| 2025-02-05 | -3.13 |
| 2025-02-04 | -2.79 |
| 2025-02-03 | -2.73 |
| 2025-01-31 | -2.83 |
| 2025-01-30 | -2.85 |
| 2025-01-29 | -2.73 |
| 2025-01-28 | -2.67 |
| 2025-01-27 | -2.73 |
| 2025-01-24 | -2.92 |
| 2025-01-23 | -2.81 |
| 2025-01-22 | -2.37 |
| 2025-01-21 | -2.48 |
| 2025-01-17 | -2.33 |
| 2025-01-16 | -2.33 |
| 2025-01-15 | -2.37 |
| 2025-01-14 | -2.28 |
| 2025-01-13 | -2.25 |
| 2025-01-10 | -2.47 |
| 2025-01-08 | -2.48 |
| 2025-01-07 | -2.77 |
| 2025-01-06 | -2.67 |
| 2025-01-03 | -2.52 |
| 2025-01-02 | -2.27 |
| 2024-12-31 | -2.35 |
| 2024-12-30 | -1.96 |
| 2024-12-27 | -1.52 |
| 2024-12-26 | -1.55 |
| 2024-12-24 | -1.65 |
| 2024-12-23 | -1.57 |
| 2024-12-20 | -1.60 |